These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6604608)

  • 1. Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease.
    Izumi N; Hasumura Y; Takeuchi J
    Clin Exp Immunol; 1983 Oct; 54(1):219-24. PubMed ID: 6604608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte cytotoxicity in alcoholic hepatitis.
    Kakumu S; Leevy CM
    Gastroenterology; 1977 Apr; 72(4 Pt 1):594-7. PubMed ID: 65306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
    Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
    Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.
    Kawanishi H; MacDermott RP
    Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
    Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
    Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test.
    Actis GC; Touscoz GA; Crivelli O; Rizzetto M; Rocca B; Poli G; Verme G
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):19-29. PubMed ID: 6206876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic aspects of alcoholic liver disease.
    Zetterman RK; Sorrell MF
    Gastroenterology; 1981 Sep; 81(3):616-24. PubMed ID: 6166511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocytotoxicity in alcoholic hepatitis: evalutation of effector cells].
    Stefanini GF; Mariani E; Facchini A; Serra S; Miglio F
    Boll Soc Ital Biol Sper; 1979 Mar; 55(5):404-10. PubMed ID: 553595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275.
    Chedid A; Mendenhall CL; Moritz TE; French SW; Chen TS; Morgan TR
    Am J Gastroenterol; 1993 Nov; 88(11):1920-7. PubMed ID: 7694454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
    Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
    J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte cytotoxicity to autologous hepatocytes in alcoholic liver disease.
    Actis G; Mieli-Vergani G; Portmann B; Eddleston AL; Davis M; Williams R
    Liver; 1983 Feb; 3(1):8-12. PubMed ID: 6602264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotype study of blood T lymphocytes in alcoholic hepatopathies].
    Pelletier G; Segond P; Attali P; Briantais MJ; Etienne JP
    Gastroenterol Clin Biol; 1984 Dec; 8(12):911-4. PubMed ID: 6394417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease.
    Izumi N; Sato C; Hasumura Y; Takeuchi J
    Clin Exp Immunol; 1985 Sep; 61(3):585-92. PubMed ID: 3907903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of (+)-cyanidanol-3 on receptor activity of lymphocytes and hepatocytes and on hepatocyte-lymphocyte conjugation in alcoholic liver disease.
    Sipos J; Gabor V; Toth Z; Ribiczey P
    Int J Tissue React; 1984; 6(2):145-54. PubMed ID: 6203861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of alcoholic liver disease.
    Leevy CB; Elbeshbeshy HA
    Clin Liver Dis; 2005 Feb; 9(1):55-66. PubMed ID: 15763229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell--mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection.
    Liaw YF; Lee CS; Tsai SL; Liaw BW; Chen TC; Sheen IS; Chu CM
    Hepatology; 1995 Nov; 22(5):1368-73. PubMed ID: 7590649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
    Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
    Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
    Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
    Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.